Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

ClinicalTrials.gov ID: NCT07218029

Public ClinicalTrials.gov record NCT07218029. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 16, 2026, 1:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH (MK-7962-038)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Researchers are looking for more ways to treat PAH. In PAH, the blood vessels in the lungs become thick and narrow, which makes it harder for blood to flow. This causes high blood pressure in the lungs and overworks the heart. PAH can make it hard to breathe and be active. Some standard (usual) treatments for PAH can treat symptoms of PAH but do not stop PAH from getting worse. Sotatercept is a study medicine designed to treat PAH. It is a targeted therapy, which is a treatment that works on certain proteins that play a role in causing PAH. This is a long-term follow-up (LTFU) study. People who took part in certain other studies testing sotatercept for PAH may be able to join this study. The goal of this study is to learn about the long-term safety of sotatercept and if people tolerate it when taken with standard PAH treatment over a longer period of time.

Study identification

NCT ID
NCT07218029
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
815 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 11, 2021
Primary completion
Dec 6, 2028
Completion
Dec 6, 2028
Last update posted
Sep 8, 2026

2021 – 2028

United States locations

U.S. sites
35
U.S. states
20
U.S. cities
32
Facility City State ZIP Site status
Pulmonary Associates, PA ( Site 1008) Phoenix Arizona 85032 Active, not recruiting
Arizona Pulmonary Specialists ( Site 1010) Scottsdale Arizona 85258 Recruiting
University of Arizona ( Site 1006) Tucson Arizona 85724-0001 Active, not recruiting
University of California San Diego Health ( Site 1002) La Jolla California 92039 Active, not recruiting
UC Irvine Health Medical Center ( Site 1086) Orange California 92868 Active, not recruiting
UC Davis - Medial Center ( Site 1064) Sacramento California 95817 Recruiting
UCSF Helen Diller Medical Center at Parnassus Heights ( Site 1019) San Francisco California 94143 Active, not recruiting
Jeffrey S. Sager, MD Medical Corporation ( Site 1060) Santa Barbara California 93105-5316 Active, not recruiting
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center ( Site 1028) Torrance California 90502 Active, not recruiting
University of Colorado Hospital ( Site 1013) Aurora Colorado 80045 Active, not recruiting
George Washington University Medical Faculty Associates ( Site 1025) Washington D.C. District of Columbia 20037 Active, not recruiting
Mayo Clinic Jacksonville ( Site 1045) Jacksonville Florida 32224 Active, not recruiting
AdventHealth Orlando ( Site 1058) Orlando Florida 32803 Active, not recruiting
Tampa General Hospital ( Site 1043) Tampa Florida 33606 Active, not recruiting
University of Kansas Medical Center ( Site 1020) Kansas City Kansas 66160 Active, not recruiting
Norton Pulmonary Specialists ( Site 1066) Louisville Kentucky 40202 Active, not recruiting
Johns Hopkins University ( Site 1036) Baltimore Maryland 21287 Active, not recruiting
Tufts Medical Center ( Site 1012) Boston Massachusetts 02111 Active, not recruiting
Brigham and Women's Hospital ( Site 1014) Boston Massachusetts 02115 Recruiting
University of Minnesota ( Site 1062) Minneapolis Minnesota 55455 Active, not recruiting
University Of Nebraska Medical Center ( Site 1053) Omaha Nebraska 68198-5990 Active, not recruiting
Weill Cornell Medical Center ( Site 1046) New York New York 10021 Active, not recruiting
Duke University Medical Center ( Site 1026) Durham North Carolina 27710-4000 Active, not recruiting
The Carl and Edyth Lindner Center for Research and Education at the Christ Hospital ( Site 1001) Cincinnati Ohio 45219 Active, not recruiting
University of Cincinnati Medical Center ( Site 1035) Cincinnati Ohio 45219 Active, not recruiting
Cleveland Clinic Main ( Site 1065) Cleveland Ohio 44195 Active, not recruiting
Ohio State University Wexner Medical Center ( Site 1032) Columbus Ohio 43210 Active, not recruiting
Oregon Health & Science University ( Site 1054) Portland Oregon 97239 Active, not recruiting
University of Pittsburgh Medical Center - Presbyterian Hosp. ( Site 1059) Pittsburgh Pennsylvania 15213 Active, not recruiting
Rhode Island Hospital ( Site 1033) Providence Rhode Island 02903 Active, not recruiting
Medical University of South Carolina ( Site 1003) Charleston South Carolina 29425 Recruiting
University of Texas Southwestern Medical Center ( Site 1038) Dallas Texas 75390 Active, not recruiting
CHI St. Luke's Health Baylor College of Medicine Medical Center ( Site 1044) Houston Texas 77030 Active, not recruiting
Houston Methodist Hospital ( Site 1009) Houston Texas 77030 Active, not recruiting
Froedtert Hospital & the Medical College of Wisconsin ( Site 1051) Milwaukee Wisconsin 53226 Active, not recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 101 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07218029, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 8, 2026 · Synced Sep 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07218029 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →